Adage Capital Partners
NMTR

Adage Capital Partners’s 9 Meters Biopharma NMTR Stock Holding History

Adage Capital Partners’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-650,000
Closed -$437K – 977
2023
Q2 		$437K Hold
650,000
– – ﹤0.01% 787
2023
Q1 		$904K Hold
650,000
– – ﹤0.01% 801
2022
Q4 		$819K Hold
650,000
– – ﹤0.01% 848
2022
Q3 		$2.79M Sell
650,000
-64,781
-9% -$321K 0.01% 832
2022
Q2 		$3.73M Sell
714,781
-35,219
-5% -$332K 0.01% 833
2022
Q1 		$8.99M Hold
750,000
– – 0.02% 726
2021
Q4 		$14.7M Hold
750,000
– – 0.03% 588
2021
Q3 		$19.5M Hold
750,000
– – 0.04% 463
2021
Q2 		$16.5M Buy
750,000
+17,500
+2% +$430K 0.03% 543
2021
Q1 		$17.1M Buy
732,500
+82,500
+13% +$2.54M 0.04% 514
2020
Q4 		$11.2M Buy
+650,000
New +$10.8M 0.02% 562

Other funds holding NMTR

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
SIS
Strategic Investment Solutions Orland Park, Illinois $437M AUM 30.41% 1-Year Est. Return
RCM
Requisite Capital Management Dallas, Texas $537M AUM 12.29% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
RFA
Register Financial Advisors Atlanta, Georgia $326M AUM 48.38% 1-Year Est. Return

Adage Capital Partners's NMTR Position: Q3 2023 in Review

Adage Capital Partners sold out of 9 Meters Biopharma (NMTR) in Q3 2023, closing a stake of 650,000 shares — an estimated $437K sold.

Adage Capital Partners first reported a position in NMTR in Q4 2020 and held it in 11 quarters. The position peaked at $19.5M in Q3 2021. 6 funds tracked by Wall St. Rank hold NMTR as of Q3 2023.

  • Adage Capital Partners reported no remaining 9 Meters Biopharma position as of Q3 2023 after selling out during the quarter.
  • Adage Capital Partners sold 650,000 9 Meters Biopharma shares in Q3 2023, an estimated $437K.
  • Adage Capital Partners first reported a position in 9 Meters Biopharma in Q4 2020 and held it in 11 quarters.
  • Adage Capital Partners's 9 Meters Biopharma position peaked at $19.5M in Q3 2021.
  • 6 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q3 2023.

Based on Adage Capital Partners's 13F filing for Q3 2023, filed 14 Nov 2023.